HCM
PFE icon

Hawkeye Capital Management’s Pfizer PFE Stock Holding History

Hawkeye Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-421,600
Closed -$11.8M – 15
2014
Q3 		$11.8M Buy
+421,600
New +$11.8M 4.75% 6

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Hawkeye Capital Management's PFE Position: Q4 2014 in Review

Hawkeye Capital Management sold out of Pfizer (PFE) in Q4 2014, closing a stake of 421,600 shares — an estimated $11.8M sold.

Hawkeye Capital Management first reported a position in PFE in Q3 2014 and held it in 1 quarter. The position peaked at $11.8M in Q3 2014. 1,860 funds tracked by Wall St. Rank hold PFE as of Q4 2014.

  • Hawkeye Capital Management reported no remaining Pfizer position as of Q4 2014 after selling out during the quarter.
  • Hawkeye Capital Management sold 421,600 Pfizer shares in Q4 2014, an estimated $11.8M.
  • Hawkeye Capital Management first reported a position in Pfizer in Q3 2014 and held it in 1 quarter.
  • Hawkeye Capital Management's Pfizer position peaked at $11.8M in Q3 2014.
  • 1,860 funds tracked by Wall St. Rank held Pfizer as of Q4 2014.

Based on Hawkeye Capital Management's 13F filing for Q4 2014, filed 18 Feb 2015.